Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Joubert

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 3, 2025
Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010-2019): A Population-Based Study Using a Machine Learning Classification AlgorithmGuy Fagherazzi, Pierre Serusclat, Barbara Roux, et al.
Annales D'Endocrinologie|May 30, 2024
Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the fieldCatherine Cardot-Bauters, Marie-Christine Vantyghem, Christine Do Cao, et al.
Diabetes, Obesity & Metabolism|October 12, 2020
Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double-blind trialMichael Joubert, Victoria Opigez, Barbora Pavlikova, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2026
Ten-Year Trends in Healthcare Use and Costs for People Living with Diabetes in France: Results from the Epicodiab Study Based on National Claims DataMichael Joubert, Pierre Serusclat, Emilie Casarotto, et al.
Nutrients|May 13, 2026
Carbohydrate Knowledge in People with Type 1 and Type 2 Diabetes in the NutriNet-Santé Cohort StudySopio Tatulashvili, Alice Bellicha, Chantal Julia, et al.
Diabetes Care|September 20, 2023
Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled TrialEric Renard, Michael Joubert, Orianne Villard, et al.
Clinical Endocrinology|November 6, 2007
Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?Michael Joubert, Estelle Louiset, Jean-Luc Do Rego, et al.
Diabetes & Metabolism|November 3, 2021
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort surveyEmilie Deberles, Remy Morello, Juliette Hardouin, et al.
Diabetes & Metabolism|May 10, 2026
Carbohydrate nutritional knowledge and diabetes outcomes according to different modes of insulin administration in people living with type 1 diabetes from the French SFDT1 cohortSopio Tatulashvili, Naima Hamamouche, Nanthara Sritharan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2022
Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 DiabetesMichael Joubert, Anaïs R Briant, Laurence Kessler, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 3, 2025
Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010-2019): A Population-Based Study Using a Machine Learning Classification AlgorithmGuy Fagherazzi, Pierre Serusclat, Barbara Roux, et al.
Annales D'Endocrinologie|May 30, 2024
Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the fieldCatherine Cardot-Bauters, Marie-Christine Vantyghem, Christine Do Cao, et al.
Diabetes, Obesity & Metabolism|October 12, 2020
Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double-blind trialMichael Joubert, Victoria Opigez, Barbora Pavlikova, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2026
Ten-Year Trends in Healthcare Use and Costs for People Living with Diabetes in France: Results from the Epicodiab Study Based on National Claims DataMichael Joubert, Pierre Serusclat, Emilie Casarotto, et al.
Nutrients|May 13, 2026
Carbohydrate Knowledge in People with Type 1 and Type 2 Diabetes in the NutriNet-Santé Cohort StudySopio Tatulashvili, Alice Bellicha, Chantal Julia, et al.
Diabetes Care|September 20, 2023
Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled TrialEric Renard, Michael Joubert, Orianne Villard, et al.
Clinical Endocrinology|November 6, 2007
Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?Michael Joubert, Estelle Louiset, Jean-Luc Do Rego, et al.
Diabetes & Metabolism|November 3, 2021
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort surveyEmilie Deberles, Remy Morello, Juliette Hardouin, et al.
Diabetes & Metabolism|May 10, 2026
Carbohydrate nutritional knowledge and diabetes outcomes according to different modes of insulin administration in people living with type 1 diabetes from the French SFDT1 cohortSopio Tatulashvili, Naima Hamamouche, Nanthara Sritharan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2022
Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 DiabetesMichael Joubert, Anaïs R Briant, Laurence Kessler, et al.
Pageof 8